Portal:Viruses


The Viruses Portal
Welcome!

Viruses are small infectious agents that can replicate only inside the living cells of an organism. Viruses infect all forms of life, including animals, plants, fungi, bacteria and archaea. They are found in almost every ecosystem on Earth and are the most abundant type of biological entity, with millions of different types, although only about 6,000 viruses have been described in detail. Some viruses cause disease in humans, and others are responsible for economically important diseases of livestock and crops.

Virus particles (known as virions) consist of genetic material, which can be either DNA or RNA, wrapped in a protein coat called the capsid; some viruses also have an outer lipid envelope. The capsid can take simple helical or icosahedral forms, or more complex structures. The average virus is about 1/100 the size of the average bacterium, and most are too small to be seen directly with an optical microscope.

The origins of viruses are unclear: some may have evolved from plasmids, others from bacteria. Viruses are sometimes considered to be a life form, because they carry genetic material, reproduce and evolve through natural selection. However they lack key characteristics (such as cell structure) that are generally considered necessary to count as life. Because they possess some but not all such qualities, viruses have been described as "organisms at the edge of life".

Selected disease

Shingles, or herpes zoster, is a painful skin rash with blisters that, characteristically, occurs in a stripe limited to just one side of the body. The rash usually heals within 2–5 weeks, but around one in five people experience residual nerve pain for months or years.

Shingles is caused by varicella zoster virus (VZV), an alpha-herpesvirus. Initial VZV infection usually occurs in childhood causing chickenpox. After this resolves, the virus is not eliminated from the body, but remains latent in the nerve cell bodies of the dorsal root or trigeminal ganglia, without causing symptoms. Years or decades later, shingles occurs when virions in a single ganglion reactivate, travel down nerve fibres and infect the skin around the nerve. The shingles rash is restricted to the area of skin supplied by a single spinal nerve, termed the dermatome. Exactly how VZV remains latent in the body, and subsequently reactivates, is unclear.

Around a third of the population will develop shingles. Repeated episodes are rare. In the United States, about half the cases occur in people aged 50 years or older. Vaccination at least halves the risk, and prompt treatment with aciclovir or related antiviral drugs can reduce the severity and duration of the rash.

Selected image

Louis Pasteur invented a vaccine against rabies, and tested it on a boy bitten by a rabid dog in 1885.

Credit: Albert Edelfelt (1885)

In the news

Map showing the prevalence of SARS-CoV-2 cases; black: highest prevalence; dark red to pink: decreasing prevalence; grey: no recorded cases or no data

26 February: In the ongoing pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), more than 110 million confirmed cases, including 2.5 million deaths, have been documented globally since the outbreak began in December 2019. WHO

18 February: Seven asymptomatic cases of avian influenza A subtype H5N8, the first documented H5N8 cases in humans, are reported in Astrakhan Oblast, Russia, after more than 100,0000 hens died on a poultry farm in December. WHO

14 February: Seven cases of Ebola virus disease are reported in Gouécké, south-east Guinea. WHO

7 February: A case of Ebola virus disease is detected in North Kivu Province of the Democratic Republic of the Congo. WHO

4 February: An outbreak of Rift Valley fever is ongoing in Kenya, with 32 human cases, including 11 deaths, since the outbreak started in November. WHO

21 November: The US Food and Drug Administration (FDA) gives emergency-use authorisation to casirivimab/imdevimab, a combination monoclonal antibody (mAb) therapy for non-hospitalised people twelve years and over with mild-to-moderate COVID-19, after granting emergency-use authorisation to the single mAb bamlanivimab earlier in the month. FDA 1, 2

18 November: The outbreak of Ebola virus disease in Équateur Province, Democratic Republic of the Congo, which started in June, has been declared over; a total of 130 cases were recorded, with 55 deaths. UN

Selected article

RNA interference is a type of gene silencing that forms an important part of the immune response against viruses and other foreign genetic material in plants and many other eukaryotes. A cell enzyme called Dicer (pictured) cleaves double-stranded RNA molecules found in the cell cytoplasm – such as the genome of an RNA virus or its replication intermediates – into short fragments termed small interfering RNAs (siRNAs). These are separated into single strands and integrated into a large multi-protein RNA-induced silencing complex, where they recognise their complementary messenger RNA (mRNA) molecules and target them for destruction. This prevents the mRNAs acting as a template for translation into proteins, and so inhibits, or silences, the expression of viral genes.

RNA interference allows the entire plant to respond to a virus after a localised encounter, as the siRNAs can transfer between cells via plasmodesmata. The protective effect can be transferred between plants by grafting. Many plant viruses have evolved elaborate mechanisms to suppress this response. RNA interference evolved early in eukaryotes, and the system is widespread. It is important in innate immunity towards viruses in some insects, but relatively little is known about its role in mammals. Research is ongoing into the application of RNA interference to antiviral treatments.

Selected outbreak

The West African Ebola epidemic was the most widespread outbreak of the disease to date. Beginning in Meliandou in southern Guinea in December 2013, it spread to adjacent Liberia and Sierra Leone, affecting the cities of Conakry and Monrovia, with minor outbreaks in Mali and Nigeria. Cases reached a peak in October 2014 and the epidemic was under control by late 2015, although occasional cases continued to occur into April 2016. Ring vaccination with the then-experimental vaccine rVSV-ZEBOV was trialled in Guinea.

More than 28,000 suspected cases were reported with more than 11,000 deaths; the case fatality rate was around 40% overall and around 58% in hospitalised patients. Early in the epidemic nearly 10% of the dead were healthcare workers. The outbreak left about 17,000 survivors, many of whom reported long-lasting post-recovery symptoms. Extreme poverty, dysfunctional healthcare systems, distrust of government after years of armed conflict, local burial customs of washing the body, the unprecedented spread of Ebola to densely populated cities, and the delay in response of several months all contributed to the failure to control the epidemic.

Selected quotation

Peter Simmonds

Selected virus

Acanthamoeba polyphaga mimivirus (APMV) is a species of DNA virus in the Mimivirus genus of the Mimiviridae family. It infects the amoeba, Acanthamoeba polyphaga. Its non-enveloped icosahedral capsid is 400 nm in diameter, with protein filaments of 100 nm projecting from its surface. The APMV genome is a linear, double-stranded DNA molecule of around 1.2 megabases, encoding around 979 genes. This is comparable to the genome of some small bacteria. It encodes several proteins that had not been previously discovered in viruses, including aminoacyl tRNA synthetases. APMV is itself parasitised by the Sputnik virophage (arrowed in micrograph).

APMV is as large as some small species of bacteria, such as Rickettsia conorii and Tropheryma whipplei. When it was first discovered in 1992, it was thought to be a bacterium, and named Bradfordcoccus. APMV was not shown to be a virus until 2003, when it was the largest virus then discovered. It has since been overtaken by Megavirus chilensis, Pandoravirus and Pithovirus, all of which also infect amoebae. These and other large and complex DNA viruses are now grouped in Nucleocytoviricota, also termed nucleocytoplasmic large DNA viruses.

Did you know?

Selected biography

Many well-known people have survived the paralytic disease polio. The earliest identified case might be Siptah (pictured), Egyptian pharaoh 1197–1191 BC, whose mummified remains have a deformed leg possibly from polio. Claudius, Roman emperor 41–54 AD, walked with a limp after a childhood disease that historians have hypothesised might have been polio. Novelist Sir Walter Scott suffered paralysis in one leg after a teething fever in 1773, which left him lame; his detailed account of his disease has allowed a retrospective diagnosis of polio to be made with confidence.

For many of those who survived it, paralytic polio was a life-changing experience. The disease can lead to permanent physical disability; Itzhak Perlman, for example, plays the violin seated. Others recover completely, with some going on to excel in sports; Ray Ewry became world's foremost standing jumper after childhood polio. Some survivors, including singer Ian Dury and actress Mia Farrow, have campaigned for polio eradication or for disability rights.

In this month

1 July 1796: Edward Jenner first challenged James Phipps with variolation, showing that cowpox inoculation is protective against smallpox

3 July 1980: Structure of southern bean mosaic virus solved by Michael Rossmann and colleagues

6 July 1885: Louis Pasteur (pictured) gave rabies vaccine to Joseph Meister

10 July 1797: Jenner submitted paper on Phipps and other cases to the Royal Society; it was read to the society but not published

14–20 July 1968: First International Congress for Virology held in Helsinki

16 July 2012: FDA approved tenofovir/emtricitabine (Truvada) for prophylactic use against HIV; first prophylactic antiretroviral

19 July 2013: Pandoravirus described, with a genome twice as large as Megavirus

22 July 1966: International Committee on Nomenclature of Viruses (later the ICTV) founded

25 July 1985: Film star Rock Hudson made his AIDS diagnosis public, increasing public awareness of the disease

28 July 2010: First global World Hepatitis Day

Selected intervention

Several human papillomavirus (HPV) vaccines, including Cervarix and Gardasil, have been approved to protect against infections with particular types of HPV, associated with cervical and other cancers. All vaccines protect against the high-risk HPV types 16 and 18. Gardasil is a quadrivalent vaccine that additionally protects against low-risk HPV-6 and -11, which are associated with most cases of genital warts. A second-generation nine-valent Gardasil vaccine protects against five additional high-risk HPV types. It is estimated that the vaccines may prevent 70% of cervical cancer, 80% of anal cancer, 60% of vaginal cancer, 40% of vulvar cancer and possibly some oropharyngeal cancers. Protection lasts for at least 8–9 years. Some advocate giving Gardasil to men and boys with the primary aim of protecting their female sexual partners; others consider vaccinating only women and girls to be more cost effective. The licensed vaccines are subunit vaccines, containing only the L1 capsid protein of the virus, which self-assembles into virus-like particles. They are not effective in people already infected with HPV. Research is ongoing into therapeutic HPV vaccines including the viral oncoproteins, E6 and E7, but none has yet been licensed.

Subcategories

Subcategories of virology:

Virology
Branches of virology
Viruses
Diagnostic virology
Viral diseases
Viral genes
History of virology
Virology journals
Viral life cycle
Virology organizations
Viral proteins
Satellite viruses
Slow virus diseases
Subviral agents
Viroids
Virologists
Virotherapy
Virucides
Viruses

Topics

Things to do

  • Comment on what you like and dislike about this portal
  • Join the Viruses WikiProject
  • Tag articles on viruses and virology with the project banner by adding {{WikiProject Viruses}} to the talk page
  • Assess unassessed articles against the project standards
  • Create requested pages: red-linked viruses | red-linked virus genera
  • Expand a virus stub into a full article, adding images, citations, references and taxoboxes, following the project guidelines
  • Create a new article (or expand an old one 5-fold) and nominate it for the main page Did You Know? section
  • Improve a B-class article and nominate it for Good Article or Featured Article status
  • Suggest articles, pictures, interesting facts, events and news to be featured here on the portal

WikiProjects & Portals

WikiProject Viruses
Related WikiProjects

Medicine • Microbiology • Molecular & Cellular Biology • Veterinary Medicine

Related Portals

Associated Wikimedia

The following Wikimedia Foundation sister projects provide more on this subject: